1 week Ago Jim Lebenthal, chief equity strategist at Cerity Partners, joins CNBC's "Halftime Report" to explain why he's buying more of the defense name..
Health
Trade Tracker: Jim Lebenthal buys more Lockheed Martin
Jim Lebenthal, chief equity strategist at Cerity Partners, joins CNBC's "Halftime Report" to explain why he's buying more of the defense name.
1 week Ago 
